For FDA Warning Letter Click Here –
Alkermes, Inc. MARCS-CMS 597260 —
- Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.